The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Open accessAbstract
Hyperuricemia is a common metabolic syndrome. Elevated uric acid levels are risk factors for gout, hypertension, and chronic kidney diseases. Furthermore, various epidemiological studies have also demonstrated an association between cardiovascular risks and hyperuricemia. In hyperuricemia, reactive oxygen species (ROS) are produced simultaneously with the formation of uric acid by xanthine oxidases. Intracellular uric acid has also been reported to promote the production of ROS. The ROS and the intracellular uric acid itself regulate several intracellular signaling pathways, and alterations in these pathways may result in the development of atherosclerotic lesions. In this review, we describe the effect of uric acid on various molecular signals and the potential mechanisms of atherosclerosis development in hyperuricemia. Furthermore, we discuss the efficacy of treatments for hyperuricemia to protect against the development of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
High Uric Acid Inhibits Cardiomyocyte Viability Through the ERK/P38 Pathway via Oxidative Stress
Li, Z., Shen, Y., Chen, Y., Zhang, G., Cheng, J., & Wang, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487356 · Cited by 60
RetractedXin, Y., Wang, K., Jia, Z., Xu, T., Xu, Q., Zhang, C., Liu, J., Chen, R., Du, Z., & Sun, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490184 · Cited by 15
RetractedAntiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
Efficacy and safety of low-dose colchicine after myocardial infarction
Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., Pinto, F. J., Ibrahim, R., Gamra, H., Kiwan, G. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1912388 · Cited by 3,159 · cited 11×
“In randomized control trials (RCTs), ULT significantly suppressed out flares in patients with asymptomatic hyperuricemia.”
BackgroundInfluentialColchicine in Patients with Chronic Coronary Disease
Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299 · cited 12×
“In randomized control trials (RCTs), ULT significantly suppressed out flares in patients with asymptomatic hyperuricemia.”
BackgroundInfluentialCeriello, A., & Motz, E. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000122852.22604.78 · Cited by 1,378 · cited 1×
“The level of oxidative stress is correlated with age [29], blood pressure [30], smoking [29], LDL cholesterol [31], and blood sugar level [32].”
BackgroundSerum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,269
Chen‐Xu, M., Yokose, C., Rai, S. K., Pillinger, M. H., & Choi, H. K. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40807 · Cited by 1,072
2020 American College of Rheumatology Guideline for the Management of Gout
FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., Gelber, A. C., Harrold, L. R., Khanna, D., King, C., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24180 · Cited by 983
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
White, W. B., Saag, K. G., Becker, M. A., Borer, J. S., Gorelick, P. B., Whelton, A., Hunt, B., Castillo, M., & Gunawardhana, L. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710895 · Cited by 909
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury
Granger, D. N. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.255.6.h1269 · Cited by 815
2020 American College of Rheumatology Guideline for the Management of Gout
FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., Gelber, A. C., Harrold, L. R., Khanna, D., King, C., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41247 · Cited by 810
Sag, D., Carling, D., Stout, R. D., & Suttles, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8633 · Cited by 796
Sautin, Y. Y., Nakagawa, T., Zharikov, S., & Johnson, R. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00600.2006 · Cited by 787
Kanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000072820.07472.3b · Cited by 786
Yu, M.-A., Sánchez-Lozada, L. G., Johnson, R. J., & Kang, D.-H. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328337da1d · Cited by 626
Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study
Bos, M. J., Koudstaal, P. J., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2006) · Stroke · doi:10.1161/01.str.0000221716.55088.d4 · Cited by 615
Inflammation in gout: mechanisms and therapeutic targets
So, A. K., & Martinon, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.155 · Cited by 608
Uric acid and inflammatory markers
Ruggiero, C., Cherubini, A., Ble, A., Bos, A. J. G., Maggio, M., Dixit, V. D., Lauretani, F., Bandinelli, S., Senin, U., & Ferrucci, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi879 · Cited by 591
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets
Muslin, A. J. (2008) · Clinical Science · doi:10.1042/cs20070430 · Cited by 494
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Badve, S. V., Pascoe, E. M., Tiku, A., Boudville, N., Brown, F. G., Cass, A., Clarke, P., Dalbeth, N., Day, R. O., de Zoysa, J. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915833 · Cited by 473
Choi, H. K., Ford, E. S., Li, C., & Curhan, G. (2007) · Arthritis Care & Research · doi:10.1002/art.22466 · Cited by 463
Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension
Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., & Struthers, A. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.746 · Cited by 463
McNally, J. S., Davis, M. E., Giddens, D. P., Saha, A., Hwang, J., Dikalov, S., Jo, H., & Harrison, D. G. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00515.2003 · Cited by 461
Soluble Uric Acid Activates the NLRP3 Inflammasome
Braga, T. T., Forni, M. F., Correa-Costa, M., Ramos, R. N., Barbuto, J. A., Branco, P., Castoldi, A., Hiyane, M. I., Davanso, M. R., Latz, E., et al. (2017) · Scientific Reports · doi:10.1038/srep39884 · Cited by 440
Vasamsetti, S. B., Karnewar, S., Kanugula, A. K., Thatipalli, A. R., Kumar, J. M., & Kotamraju, S. (2015) · Diabetes · doi:10.2337/db14-1225 · Cited by 397
Alvarez-Lario, B., & Macarron-Vicente, J. (2010) · Rheumatology · doi:10.1093/rheumatology/keq204 · Cited by 391
Nishino, T., Okamoto, K., Eger, B. T., Pai, E. F., & Nishino, T. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06489.x · Cited by 384
Yu, Z. F., Bruce-Keller, A. J., Goodman, Y., & Mattson, M. P. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5<613::aid-jnr11>3.0.co;2-1 · Cited by 359
Mackenzie, I. S., Ford, I., Nuki, G., Hallas, J., Hawkey, C. J., Webster, J., Ralston, S. H., Walters, M., Robertson, M., De Caterina, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32234-0 · Cited by 352
Sánchez-Lozada, L. G., Lanaspa, M. A., Cristóbal-García, M., García-Arroyo, F., Soto, V., Cruz-Robles, D., Nakagawa, T., Yu, M. A., Kang, D.-H., & Johnson, R. J. (2012) · Nephron Experimental Nephrology · doi:10.1159/000345509 · Cited by 340
A concise history of gout and hyperuricemia and their treatment.
Nuki, G., & Simkin, P. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1906 · Cited by 331
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Joosten, L. A. B., Crişan, T. O., Bjornstad, P., & Johnson, R. J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0334-3 · Cited by 319
Uric Acid and Cardiovascular Events: A Mendelian Randomization Study
Kleber, M. E., Delgado, G., Grammer, T. B., Silbernagel, G., Huang, J., Krämer, B. K., Ritz, E., & März, W. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070660 · Cited by 299
Loss of Akt1 Leads to Severe Atherosclerosis and Occlusive Coronary Artery Disease
Fernández-Hernando, C., Ackah, E., Yu, J., Suárez, Y., Murata, T., Iwakiri, Y., Prendergast, J., Miao, R. Q., Birnbaum, M. J., & Sessa, W. C. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.007 · Cited by 284
Choi, Y.-J., Shin, H.-S., Choi, H. S., Park, J.-W., Jo, I., Oh, E.-S., Lee, K.-Y., Lee, B.-H., Johnson, R. J., & Kang, D.-H. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.98 · Cited by 283
Zhao, G., Huang, L., Song, M., & Song, Y. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.023 · Cited by 282
Serum Uric Acid and Risk of Coronary Heart Disease
Moriarity, J. T., Folsom, A. R., Iribarren, C., Nieto, F. J., & Rosamond, W. D. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00037-x · Cited by 280
Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation
Ives, A., Nomura, J., Martinon, F., Roger, T., LeRoy, D., Miner, J. N., Simon, G., Busso, N., & So, A. (2015) · Nature Communications · doi:10.1038/ncomms7555 · Cited by 264
Serum urate as an antioxidant for ascorbic acid
Sevanian, A., Davies, K., & Hochstein, P. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.1129s · Cited by 261
Li, M., Hu, X., Fan, Y., Li, K., Zhang, X., Hou, W., & Tang, Z. (2016) · Scientific Reports · doi:10.1038/srep19520 · Cited by 257
The genetics of hyperuricaemia and gout
Reginato, A. M., Mount, D. B., Yang, I., & Choi, H. K. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.144 · Cited by 251
Relationship between Oxidative Stress and Essential Hypertension
RODRIGO, R., PRAT, H., PASSALACQUA, W., ARAYA, J., GUICHARD, C., & BÄCHLER, J. P. (2007) · Hypertension Research · doi:10.1291/hypres.30.1159 · Cited by 235
Gout and hyperuricaemia in the USA: prevalence and trends
Singh, G., Lingala, B., & Mithal, A. (2019) · Rheumatology · doi:10.1093/rheumatology/kez196 · Cited by 230
Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers
Guthikonda, S., Sinkey, C., Barenz, T., & Haynes, W. G. (2003) · Circulation · doi:10.1161/01.cir.0000046448.26751.58 · Cited by 225
Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.
Li, L., Zhang, Y., & Zeng, C. (2020) · PubMed Central · Cited by 201
Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Lanaspa, M. A., Cicerchi, C., Garcia, G., Li, N., Roncal-Jimenez, C. A., Rivard, C. J., Hunter, B., Andrés-Hernando, A., Ishimoto, T., Sánchez-Lozada, L. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048801 · Cited by 193
Keenan, T., Zhao, W., Rasheed, A., Ho, W. K., Malik, R., Felix, J. F., Young, R., Shah, N., Samuel, M., Sheikh, N., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.086 · Cited by 188
Bredemeier, M., Lopes, L. M., Eisenreich, M. A., Hickmann, S., Bongiorno, G. K., d’Avila, R., Morsch, A. L. B., da Silva Stein, F., & Campos, G. G. D. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0757-9 · Cited by 188
Xanthine Oxidoreductase Is a Regulator of Adipogenesis and PPARγ Activity
Cheung, K. J., Tzameli, I., Pissios, P., Rovira, I., Gavrilova, O., Ohtsubo, T., Chen, Z., Finkel, T., Flier, J. S., & Friedman, J. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.005 · Cited by 187
Cicerchi, C., Li, N., Kratzer, J., Garcia, G., Roncal‐Jimenez, C. A., Tanabe, K., Hunter, B., Rivard, C. J., Sautin, Y. Y., Gaucher, E. A., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-243634 · Cited by 187
Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress
Battelli, M. G., Polito, L., & Bolognesi, A. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.006 · Cited by 179
Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies
Zuo, T., Liu, X., Jiang, L., Mao, S., Yin, X., & Guo, L. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0379-z · Cited by 178
Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway
Cai, W., Duan, X.-M., Liu, Y., Yu, J., Tang, Y.-L., Liu, Z.-L., Jiang, S., Zhang, C.-P., Liu, J.-Y., & Xu, J.-X. (2017) · BioMed Research International · doi:10.1155/2017/4391920 · Cited by 178
Yu, E. P. K., Reinhold, J., Yu, H., Starks, L., Uryga, A. K., Foote, K., Finigan, A., Figg, N., Pung, Y.-F., Logan, A., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.310042 · Cited by 170
Uric acid priming in human monocytes is driven by the AKT–PRAS40 autophagy pathway
Crişan, T. O., Cleophas, M. C. P., Novakovic, B., Erler, K., van de Veerdonk, F. L., Stunnenberg, H. G., Netea, M. G., Dinarello, C. A., & Joosten, L. A. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620910114 · Cited by 165
Mitochondrial Dysfunction in Atherosclerosis
Peng, W., Cai, G., Xia, Y., Chen, J., Wu, P., Wang, Z., Li, G., & Wei, D. (2019) · DNA and Cell Biology · doi:10.1089/dna.2018.4552 · Cited by 165
Kimura, Y., Yanagida, T., Onda, A., Tsukui, D., Hosoyamada, M., & Kono, H. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313224 · Cited by 165
Self-citationRole of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis
Reustle, A., & Torzewski, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123761 · Cited by 163
Yuan, Y., Chen, Y., Peng, T., Li, L., Zhu, W., Liu, F., Liu, S., An, X., Luo, R., Cheng, J., et al. (2019) · Clinical Science · doi:10.1042/cs20190672 · Cited by 158
Recent advances in fructose intake and risk of hyperuricemia
Zhang, C., Li, L., Zhang, Y., & Zeng, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110795 · Cited by 156
Verzola, D., Ratto, E., Villaggio, B., Parodi, E. L., Pontremoli, R., Garibotto, G., & Viazzi, F. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115210 · Cited by 155
AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging
Cordero, M. D., Williams, M. R., & Ryffel, B. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.10.009 · Cited by 154
Yang, Q., Xu, J., Ma, Q., Liu, Z., Varadarajan, S., Cao, Y., Wang, L., Zeng, X., Zhou, Y., Zhang, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07132-x · Cited by 145
Patetsios, P., Song, M., Shutze, W. P., Pappas, C., Rodino, W., Ramirez, J. A., & Panetta, T. F. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01621-6 · Cited by 143
Klauser, A. S., Halpern, E. J., Strobl, S., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3201 · Cited by 140
Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study
Solh, A. A. E., Saliba, R. M., Bosinski, T. J., Grant, B. J. B., Berbary, E., & Miller, N. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00101005 · Cited by 136
Kushiyama, A., Okubo, H., Sakoda, H., Kikuchi, T., Fujishiro, M., Sato, H., Kushiyama, S., Iwashita, M., Nishimura, F., Fukushima, T., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234559 · Cited by 130
Krishnan, E., Pandya, B. J., Chung, L. S., & Dabbous, O. H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3322 · Cited by 129
Zhang, Y., Yamamoto, T., Hisatome, I., Li, Y., Cheng, W., Sun, N., Cai, B., Huang, T., Zhu, Y., Li, Z., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.027 · Cited by 128
Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
Sun, H., Wu, Y.-W., Bian, H., Yang, H., Wang, H., Meng, X., & Jin, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667753 · Cited by 125
van der Schaft, N., Brahimaj, A., Wen, K., Franco, O. H., & Dehghan, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179482 · Cited by 121
Role of PI3K in the Progression and Regression of Atherosclerosis
Zhao, Y., Qian, Y., Sun, Z., Shen, X., Cai, Y., Li, L., & Wang, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632378 · Cited by 118
Impact of allopurinol on risk of myocardial infarction
Grimaldi‐Bensouda, L., Alpérovitch, A., Aubrun, E., Danchin, N., Rossignol, M., Abenhaim, L., & Richette, P. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202972 · Cited by 112
Role of xanthine oxidase in ischemia/reperfusion injury
Linas, S. L., Whittenburg, D., & Repine, J. E. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.3.f711 · Cited by 109
Andrés, M., Quintanilla, M. A., Sivera, F., Sánchez–Payá, J., Pascual, E., Vela, P., & Ruiz-Nodar, J. M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39581 · Cited by 107
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout
Kim, S. C., Neogi, T., Kang, E. H., Liu, J., Desai, R. J., Zhang, M., & Solomon, D. H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.052 · Cited by 105
Tanaka, A., Taguchi, I., Teragawa, H., Ishizaka, N., Kanzaki, Y., Tomiyama, H., Sata, M., Sezai, A., Eguchi, K., Kato, T., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003095 · Cited by 103
NADPH Oxidases and Their Role in Atherosclerosis
Poznyak, A. V., Grechko, A. V., Orekhova, V. A., Khotina, V. A., Ivanova, E. A., & Orekhov, A. N. (2020) · Biomedicines · doi:10.3390/biomedicines8070206 · Cited by 100
Pérez-Ruiz, F., Aniel-Quiroga, M. A., Herrero-Beites, A. M., Chinchilla, S. P., Erauzkin, G. G., & Merriman, T. (2015) · Rheumatology International · doi:10.1007/s00296-015-3242-0 · Cited by 99
Mackenzie, I. S., Ford, I., Walker, A., Hawkey, C. J., Begg, A. G., Avery, A. J., Taggar, J., Wei, L., Struthers, A. D., & MacDonald, T. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013774 · Cited by 99
Sun, H., Pei, D., Lue, K., & Chen, Y.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143786 · Cited by 98
Zhang, T., & Pope, J. E. (2017) · Rheumatology · doi:10.1093/rheumatology/kex065 · Cited by 97
Cytokine Profile in Gout: Inflammation Driven by IL-6 and IL-18?
Cavalcanti, N. G., Marques, C. D. L., Lins, T. U. L. E., Pereira, M. C., Rêgo, M. J. B. D. M., Duarte, Â. L. B. P., Pitta, I. D. R., & Pitta, M. G. D. R. (2016) · Immunological Investigations · doi:10.3109/08820139.2016.1153651 · Cited by 95
Monosodium urate crystals trigger Nrf2- and heme oxygenase-1-dependent inflammation in THP-1 cells
Jhang, J., Cheng, Y., Ho, C.-Y., & Yen, G. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.65 · Cited by 94
AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE−/− mice
Ma, A., Wang, J., Liu, Y., An, Y., & Zhu, H. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m073270 · Cited by 91
Nomura, J., Busso, N., Ives, A., Tsujimoto, S., Tamura, M., So, A. K.-L., & Yamanaka, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075527 · Cited by 82
Chao, H., Liu, J., Lin, J., Chen, C., Wu, C., & Cheng, T.-H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00877.x · Cited by 80
Uric acid induced inflammatory responses in endothelial cells via up-regulating(pro)renin receptor
Yang, X., Gu, J., Lv, H., Li, H., Cheng, Y., Liu, Y., & Jiang, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.129 · Cited by 80
Interaction between uric acid and HMGB1 translocation and release from endothelial cells
Rabadi, M. M., Kuo, M., Ghaly, T., Rabadi, S. M., Weber, M., Goligorsky, M. S., & Ratliff, B. B. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2011 · Cited by 79
AkifumiKushiyama, HirofumiOkubo, HideyukiSakoda, TakakoKikuchi, MidoriFujishiro, HirokazuSato, SakuraKushiyama, MisakiIwashita, FusanoriNishimura, ToshiakiFukushima, et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · Cited by 79
Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study
Larsen, K. S., Pottegård, A., Lindegaard, H., & Hallas, J. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.11.003 · Cited by 74
Kırça, M., Oğuz, N., Çetin, A., Uzuner, F., & Yeşilkaya, A. (2016) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2016.1203941 · Cited by 62
Alem, M. M. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12432 · Cited by 60
Chiang, K.-M., Tsay, Y., Ng, T.-C. V., Yang, H., Huang, Y., Chen, C., & Pan, W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081202 · Cited by 53
Al‐Benna, S., Hamilton, C., McClure, J., Rogers, P. N., Berg, G. A., Ford, I., Delles, C., & Dominiczak, A. F. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000193626.22269.45 · Cited by 51
Luo, C., Lian, X., Hong, L., Zou, J., Li, Z., Zhu, Y., Huang, T., Zhang, Y., Hu, Y., Yuan, H., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452567 · Cited by 51
Sunagawa, S., Shirakura, T., Hokama, N., Kozuka, C., Yonamine, M., Namba, T., Morishima, S., Nakachi, S., Nishi, Y., Ikema, T., et al. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12870 · Cited by 51
Effect of uric acid on mitochondrial function and oxidative stress in hepatocytes
Yang, Y., Zhou, Y., Cheng, S., Sun, J., Yao, H., & Ma, L. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15028644 · Cited by 50
Lim, S. S., Yang, Y., Chen, S., Wu, C., Huang, S., Chan, W., Lin, S., Chen, J., Chou, C.-Y., Pan, J., et al. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.01.025 · Cited by 50
Martínez‐Hervás, S., Real, J. T., Ivorra, C., Priego, A., Chaves, F. J., Pallardó, F. V., Vinã, J. R., Redón, J., Carmena, R., & Ascaso, J. F. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.06.003 · Cited by 35
High uric acid promotes dysfunction in pancreatic β cells by blocking IRS2/AKT signalling
Hu, Y., Zhao, H., Lu, J., Xie, D., Wang, Q., Huang, T., Xin, H., Hisatome, I., Yamamoto, T., Wang, W., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111070 · Cited by 35
Lytvyn, Y., Har, R. L. H., Locke, A., LAI, V. S., Fong, D., Advani, A., Perkins, B. A., & Cherney, D. Z. I. (2017) · Diabetes · doi:10.2337/db17-0168 · Cited by 34
Sugiura, T., Dohi, Y., Takase, H., Yamashita, S., Fujii, S., & Ohte, N. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.39289 · Cited by 34
Sensing soluble uric acid by Naip1-Nlrp3 platform
Braga, T. T., Davanso, M. R., Mendes, D., de Souza, T. A., Brito, A. F., Cruz, M. C., Hiyane, M. I., de Lima, D. S., Leal, V. N. C., Giarola, J. D. F., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03445-w · Cited by 34
Roman, Y. M. (2019) · Europe PMC (PubMed Central) · Cited by 33
Huang, Y., Zhang, C., Xu, Z.-Q. J., Shen, J., Zhang, X., Du, H., Zhang, K., & Zhang, D. (2017) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2017.01.004 · Cited by 28
Nakata, T., Ikeda, S., Koga, S., Yonekura, T., Tsuneto, A., Doi, Y., Fukae, S., Minami, T., Kawano, H., & Maemura, K. (2020) · International Heart Journal · doi:10.1536/ihj.20-114 · Cited by 26
López‐Cruz, R. I., Crocker, D. E., Gaxiola‐Robles, R., Bernal-Vertiz, J. A., Real-Valle, R. A., Lugo-Lugo, O., & Zenteno‐Savín, T. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00213 · Cited by 23
García‐Arroyo, F. E., Monroy-Sánchez, F., Muñoz-Jiménez, I., Gonzaga, G., Andrés-Hernando, A., Zazueta, C., Juárez-Rojas, J. G., Lanaspa, M. A., Johnson, R. J., & Sánchez‐Lozada, L. G. (2019) · Biomolecules · doi:10.3390/biom9100601 · Cited by 22
Su, Y. A., Hu, L., Wang, Y., Ying, G., Ma, C., & Wei, J. (2021) · Journal of International Medical Research · doi:10.1177/03000605211021752 · Cited by 14
Choe, J., Choi, C.-H., Park, K., & Kim, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.139 · Cited by 12
Cited by
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
The Role of Oxidative Stress in Atherosclerosis
Batty, M., Bennett, M. R., & Yu, E. (2022) · Cells · doi:10.3390/cells11233843 · Cited by 536
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Gherghina, M.-E., Peride, I., Tiglis, M., Neagu, T. P., Niculae, A., & Checherita, I. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063188 · Cited by 501
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Copur, S., Demiray, A., & Kanbay, M. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.04.022 · Cited by 287
Metadata
- Authors
- Kimura, Y., Tsukui, D., & Kono, H.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-11-17
- Volume
- 22
- Issue
- 22
- Pages
- 12394
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3214382627
- Cited by
- 309
- References
- 116
- FWCI
- 25.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.